Matthias Alder - Mar 26, 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Chief Executive Officer, Director
Signature
/s/ Matthias Alder
Stock symbol
GANX
Transactions as of
Mar 26, 2024
Transactions value $
-$24,705
Form type
4
Date filed
3/28/2024, 09:00 PM
Previous filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Options Exercise +18.8K +267.36% 25.8K Mar 26, 2024 Direct F1
transaction GANX Common Stock Options Exercise +825 +3.2% 26.6K Mar 26, 2024 Direct F1
transaction GANX Common Stock Options Exercise +637 +2.4% 27.2K Mar 26, 2024 Direct F1
transaction GANX Common Stock Tax liability -$24.7K -6.09K -22.35% $4.06 21.1K Mar 26, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Restricted Stock Units Options Exercise $0 -18.8K -25% $0.00 56.3K Mar 26, 2024 Common Stock 18.8K Direct F1, F3
transaction GANX Restricted Stock Units Options Exercise $0 -825 -9.09% $0.00 8.25K Mar 26, 2024 Common Stock 249 Direct F1, F4
transaction GANX Restricted Stock Units Options Exercise $0 -637 -9.08% $0.00 6.38K Mar 26, 2024 Common Stock 192 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
F3 The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
F4 The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.